♦ In its Rouen laboratory, SGS, world leader in testing, inspection and certification, has specialized in chemical, physicochemical and ecotoxicological analyses for several decades. ♦ Since 2021, SGS has been offering cosmetics manufacturers and distributors a unique analysis method for testing the 57 allergens defined in SCCS opinion 1459/11 of June 2012, and which is currently the subject of a draft European regulation, with entry into force scheduled for the 1st quarter of 2022. ♦ Adapted from IFRA, this new method has been developed using gas chromatography (GC) coupled with mass spectrometry (MS). Its reduced number of injections per sample saves time in data reprocessing. In addition to ingredients, analyses are particularly focused on finished products, as the presence of possible allergen precursors and the instability of certain formulas can generate allergens not predicted during the development phase.
After nickel allergy, fragrance allergy is the most widespread skin allergy. Fragrances are almost always present in cosmetic products, whether in the form of synthetic substances or of natural origin, such as essential oils. They can potentially trigger a contact allergy affecting the skin, generally the face, armpits and hands, or cause skin irritation in certain individuals, such as eczema. The SGS Rouen laboratory, specialized in chemical, physico-chemical and ecotoxicological analyses, employs over 100 people and processes around 50,000 samples a year, from all sectors of activity, including cosmetics, detergents and hygiene products. It has state-of-the-art equipment, including chromatographic and spectral techniques, enabling it to search for trace chemical substances covered by regulations. To meet the needs of manufacturers and distributors of cosmetic products, relating to the 57 allergens defined in the SCCS notice 1459/11 of June 2012, SGS has developed a unique method of analysis. Adapted from the Ifra method, it was developed using gas chromatography coupled with mass spectrometry (GC/MS). It allows to detect and quantify that the 57 fragrances, including some isomers, have a concentration lower than 0.001% in the non rinsed products and 0.01% in the rinsed products. Above these concentrations, allergens will have to be labelled to inform the consumer. " To enable analysis of finished products and complex matrices, we have adapted the IFRA method, originally developed for perfumery ingredients. We use two columns of different polarity and systematic matrix doping to guarantee the reliability of our results. Based on our experience, we recommend carrying out these analyses on finished products, due to possible interactions when mixing ingredients, the possible presence of allergen precursors and the instability of certain formulas over time. In this way, customers can guarantee the conformity of their products right up to their estimated end-of-life. "says Audrey Guibet, Cosmetics & Hygiene strategic expert, SGS France. Consumers will be warned of allergenic components in the list of ingredients labelled on the product (INCI list). The higher the concentration of an ingredient present, the higher its position in the INCI list. " This analysis of finished products enables us to guarantee manufacturers, distributors and consumers that our cosmetic products comply with current and future regulations. "concludes Carine Dumas, Cosmetics & Hygiene Development Manager, SGS France.
Regulatory requirements*:
To date, 25** allergens have been tested and must be labeled if present {** Lirai banned since August 2021).
The SCCS opinion 1459/11 of June 2012, which recommended informing consumers about the presence of 62 additional allergens, is the subject of a regulation that will come into force in 2022.
In all, 87*** allergenic substances will have to be monitored. *** Of these 87 substances, 57 are currently technically analyzable, as the NF EN 16274 standard will be updated in September 2021. Not all allergens are covered by this method, as some are complex mixtures such as plant extracts. Application timetable :
Adoption of regulations: 1st quarter 2022
2*™ quarter 2025: ban on marketing non-compliant products.
2nd quarter 2027: withdrawal of non-compliant products from the market.
For the continuation of our series dedicated to the Pharmatech Cosmetech trade show and its innovations, watch two new episodes.
Episode 29 This time, interviews with a more "machines and production tools" slant. You'll be able to listen to Jérome Cheron from E+E Elektronik talking about sensors; Jean-Louis Fontanilles from Sotic on the subject of geared motors; Jérémy Dupuy from RS Components focusing on services for good industrial maintenance; and a duo: Philippe Gomes and Bruno Quaegebeur from Soretrac talking about eco-designed packaging films.
Episode 30: To conclude the series, we invite you to listen to Soline Godet from Cosmetic Valley, who will talk about ... Then Paul-Arthur Sol from Mettler Toledo, who focuses on pure and ultra-pure water analysis. Then it's Mehdy Abadou's turn to talk about Bürkert's new products, including a flowmeter that replaces mastic flowmeters. Finally, Pascal Billy, representing CDA, will talk about filling, capping and labeling lines...
The only solution on the market dedicated to the inspection of lyophilized vials in sterile environments, the Raised Stopper Inspection (RSI) features a high-performance camera system and manages the zone between the cap and the capping, previously uninspected in primary pharmaceutical packaging.
Antares Vision Group, the Italian leader in traceability, product protection, visual inspection, tracking solutions and intelligent data management, based in Lyon (69), France, took part for the 5th year running in Pharmapack, the European pharmaceutical packaging trade show held at Paris Expo - Porte de Versailles on May 18 & 19, 2022.
On its stand C38 in Hall 7.2, Antares Vision Group will be presenting Raised Stopper Inspection, an innovative solution for detecting industrial errors in the stoppering of bottles in sterile environments.
RSI reduces the risk of air ingress and contamination
Developed to acclimatize to sterile Good Manufacturing Practices (GMP) manufacturing environments, Raised Stopper Inspection is designed to :
Detect the space between the neck and the base of the bottle cap;
Reject those whose caps do not fully adhere to the flask collars, such as tilted, incorrectly positioned, missing or damaged caps.
The risk of air ingress and contamination is reduced, and in the event of repeated faults, the machine provides immediate feedback to pharmaceutical manufacturers.
Raised Stopper Inspection technology is part of Antares Vision's Track&Trace Solutions.
It makes it possible to manage the area between capping and closure, previously uncontrolled in primary pharmaceutical packaging.
Raised Stopper Inspection lends itself to the development of new vision applications in sterile and non-sterile pharmaceutical operations.
Compact (total length 760 mm) and self-contained, Raised Stopper Inspection is specifically designed for detection in sterile environments, and can be integrated into both existing and new lines.
The RSI on display on Antares Vision Group stand C38 at PharmaPack Paris.
RSI is at the service of performance!
Inspection speed: up to 30 units/min.
Compatible with a wide range of bottles, from 10 to 300 ml, and caps, from 20 to 32mm.
Quick format changeover: just 15 minutes!
Antares Vision Group: a global presence
The Group is present in over 60 countries with its comprehensive, flexible hardware and software solutions and associated services.
Antares Vision Group has 7 production sites in Italy (Brescia, Parma, Piacenza, Latina, Collecchio, Mestrino and Vicenza), 22 foreign subsidiaries (Germany, France [3], USA [7], Latin America [2], UK, Spain, South Korea, India, Russia, Hong Kong, China, Croatia and Serbia), 3 Innovation and Research Centers (Italy) and a worldwide network of over 40 partners.
Thanks to the two founding partners' twenty years' experience in vision technologies, the Antares Vision Group is a supplier to 10 of the world's top 20 pharmaceutical industries, with over 25,000 inspection systems guaranteeing product safety and quality on a daily basis, 6,500 quality controls and over 3,500 serialization modules on lines installed worldwide.
Antares Vision Group: a strategy of strong growth
To support growth and the development strategy initiated in 2019, we have finalized shareholding agreements with T2 Software, a Brazilian company specializing in intelligent data management solutions, and Orobix, a leading Italian company in artificial intelligence services, as well as the acquisition of 100 % from FT System, a leader in control and inspection in the beverage sector.
In 2020, Antares Vision Group acquired 82.83 % of Tradeticity, a Croatian company specializing in traceability management software and serialization processes, 100% of Convel, an Italian company specializing in automated machine inspection for the pharmaceutical industry, the assets of Adents High Tech International, a French company specializing in serialization and traceability software, 100% of Applied Vision, a leader in inspection systems for glass and metal containers in the food industry.
In March 2021, Antares Vision Group acquired 100 % from rfXcel Corporation, a US-based specialist in software solutions for supply chain digitization and transparency, and 100 % from Pen-Tec and Tecnel, via FT System, a growing specialization in the food and beverage inspection sector. And as recently as September 2021, Antares Vision Group signed an agreement with Russia's Baikalsea to ensure the traceability of mineral water bottles.
Held in Chartres from May 31 to June 2, 2022, the Pharmatech Cosmetech trade show brings together industry professionals to present new products and market trends.
We set up our studio at the heart of the show and interview partners, exhibitors and visitors...
Discover the interviews from the first day of the show in two episodes.
Episode 27 Meet Julie Voyer, show director; Jean-Marc Lenoir for Olsa, Sophie De Reynal for Nutrimarketing and Hervé Baillieu and Virgile Duclos for Dr Paul Lohmann.
Episode 28 These include: Scortex, represented by Aymeric de Pontbriand, who is banking on the digitization of quality control; Dynamic and Virginie Subileau, who are presenting the mixers in the Misceo range; and Rémi Turbet-Delof, who is representing Antares Vision and its tools for guaranteeing product authenticity...
Croda International Pic, the company that uses smart science to create specialty chemical ingredients, is excited to announce that it will support this year's IFSCC conference as a Platinum Sponsor.
With a focus on meeting changing consumer needs while committing to sustainability and social responsibility, Croda Personal Care is a global player that develops creative and trendy solutions through innovation, technical expertise and sustainability. The sponsorship of this event demonstrates Croda's commitment to innovation in the cosmetics industry, but also aims to celebrate its long history of market-leading innovation.
The 32nd IFSCC Congress will take place September 19-22 in London and Croda is particularly proud, as a UK-based company, to support this year's event there, strengthening the link to innovation in the beauty industry. The theme for this year's IFSCC is "Where Beauty, Science and Innovation Meet". This theme fits perfectly with Croda's ambition for innovation, but it also reflects the need for partnerships and collaborations to drive real change for the future. This theme comes at a time when collaboration within the industry is essential, in order to meet the challenges facing the world today and build a more sustainable future for all. Dr. Tony Gough, IFSCC president-elect, said, " We are delighted to welcome Croda as a Platinum Sponsor of the 32nd IFSCC Congress, a prestigious event that would not be possible without the support of such a generous sponsor. IFSCC 2022 will be a wonderful event filled with high quality presentations on the latest cosmetic science."
Laura Willemsen, Vice President - Consumer Care Marketing at Croda, added: " IFSCC brings together industry players to successfully introduce science and technology for the cosmetics industry. Croda's goal is to put smart science to work to improve lives, and our teams regularly work with partners on new innovations and science to meet the ever-changing needs of consumers. The themes of this year's conference resonate with our science and innovation priorities, and we are excited to contribute and showcase concepts from our Beauty Actives and Beauty Formulations R&T teams and engage with our partners on new scientific developments and opportunities. It is a pleasure to support the organization of the London edition, close to our headquarters in Yorkshire, UK."
Dr. Tony Gough continues: " The event will bring together academic researchers, scientists and formulators from around the world, creating the perfect environment for the cross-fertilization of ideas to inspire. Demand to present in London has been high, despite the uncertainty that remains in some parts of the world, reflecting the prestige associated with attending the IFSCC. With the program now announced, final preparations are underway and IFSCC 2022 will soon be a reality. We look forward to seeing you in London in September!"
As a well-known and respected global supplier of specialty ingredients to the beauty industry, Croda is extremely proud to be able to sponsor this event that aims to push the boundaries of innovation and inspire collaboration.
In her new position, Marie will oversee operations for the Americas market and streamline the business development process. She will put in place effective systems to meet the needs of the organization and clients. Prior to her promotion, Marie led Coptis' business development team for the Americas for 10 years, with the mission of digitizing research and development labs. Anne Karagoz, president of Coptis, said, " Marie has helped position Coptis as a leading provider of PLM software solutions for the cosmetics industry in the Americas. " Marie brings over twenty years of combined R&D and sales execution experience. A former NYSCC President and current CSC Zone 1 Director, Marie holds a B.S. in Biochemistry from Douglass college at Rutgers University, an M.S. in Cosmetic Science from Fairleigh Dickinson University, and an MBA from Norm Brodsky College of Business at Rider University. For the past 20 years, Coptis has been at the forefront of software solutions for cosmetic laboratories. Coptis Lab, the company's flagship product, is a PLM software for formulation development and international regulatory compliance. The software and associated databases enable the cosmetics industry to efficiently manage development projects, ensure compliance, reduce time to market and improve the quality and reliability of information. Coptis is actively working on cutting-edge technologies, including artificial intelligence, to further improve innovation in cosmetic product design.
Founded on May 30, 1962 in Castres by a young pharmacist, entrepreneur at heart and botany enthusiast, the Pierre Fabre Group is preparing to celebrate its 60th anniversary. In the space of 6 decades, without ever renouncing its Occitan roots, Pierre Fabre has become a world-class player in oncology, dermatology and dermo-cosmetics. 95% of its industrial production is carried out between Tarn, Flérault, Gers, Lot and Loiret and more than two-thirds is exported to 116 countries.
It all began in a pharmacy located on Place Jean-Jaurès in Castres, Pierre Fabre's hometown. It was here that the young pharmacist, a start-upper before his time, developed his first drug in the late 1950s. It was Cyclo 3, a veinotonic created from an active ingredient extracted from the roots of a local shrub: the little holly. Cyclo 3, which represented a real therapeutic advance for the time.
The enthusiastic reception Cyclo 3 received from the patients of his pharmacy convinced Pierre Fabre to found his own company. This was done on May 30, 1962, the day the articles of association of Laboratoires Pierre Fabre were officially registered with the Castres Commercial Court.
" Like the little holly tree that remains green and leafy in all seasons, the Pierre Fabre Group has never stopped growing since 1962. Six decades of innovation at the service of patients and consumers, six decades of working to strengthen the link between medicine and naturalness, six decades of radiating throughout the world while remaining faithful to our region of origin. We are proud of our Group's history, rich in the humanistic values instilled by our founder. He was a visionary who understood well before his time that there can be no progress without respect for Nature and Man. "comments Marc Alias, Director of Communications & Engagement.
In 2021, Pierre Fabre achieved a turnover of 2.5 billion euros, divided between Medicines (45%) and Dermo-cosmetics (55%), two thirds of which were generated outside France. This international reach does not prevent the Group from making "Made in France" a strategic priority. More than 95% of the products manufactured by the Group in 7 plants located in the departments of Tarn, Hérault, Gers, Lot and Loiret. Pierre Fabre employs 5300 people in France (out of 9600). 68% are based in Occitania where the Group concentrates its main decision-making centers and makes significant investments each year.
60 years after its creation and the launch of Cyclo 3, Pierre Fabre generates 62% of its sales with products whose active ingredients are derived from nature. 75% of the plants used are cultivated without phytosanitary treatments (nearly half of which are organic), with the Group cultivating 181 hectares of organic farmland in the Tarn region. Each year, its researchers develop between 3 and 5 new organic plant active ingredients or eco-extracts.
On the occasion of its 60th anniversary, the Pierre Fabre Group is opening its doors to the public in the Tarn region:
An ephemeral "Pierre Fabre village", set up in the heart of Castres from July 8 to 10, will present all of the Group's activities to the public through some forty events.
For the first time, the general public will have the opportunity to discover two emblematic sites of the Pierre Fabre Group: every Tuesday morning, between 8:30 a.m. and 12:00 p.m., a tour organized in partnership with the Castres tourist office will allow visitors to discover the Botanical Conservatory of Cambounet-sur-le-Sor, where the Group houses 916 varieties of plants (254 of which are endangered), and the manufacturing plant for dermo-cosmetic specialties in Soual.
To commemorate the Group's 60th anniversary, let's go back in time and relive some of the key moments in its history.
1951 - A force that will ... At the age of 25, Pierre Fabre made a decision that would change his life: he obtained a loan from the bank to open a pharmacy in his hometown in the Tarn. In 1958, the pharmacist developed Cyclo 3, based on local holly, to help his patients fight their problems of heavy legs and blood circulation. The success of Cyclo 3 allowed Pierre Fabre to found his own company in 1962. This man, a visionary, was extremely involved in the development of the and takes care of everything. He visits the manufacturers to check the manufacturing conditions of the plant extract. And it is still him who goes on the road with his product in his briefcase to meet doctors and pharmacists, in Paris, Bordeaux and as far as Alsace.
1962 The birth of Pierre Fabre Laboratories On the strength of his first commercial success and an entrepreneur at heart, Pierre Fabre decided to combine a vocation, pharmacy, with a passion, botany. This is how the Pierre Fabre Laboratories came into being. A building was built to house the first employees who worked in research and manufacturing. Little by little, the young laboratory's portfolio was expanded to include new medicines.
1965 The invention of dermo-cosmetics Klorane shampoo with chamomile marks the launch of a new activity: dermo-cosmetics, which will be the exclusive preserve of pharmacies. This was a founding moment in the company's history, reflecting Pierre Fabre's desire to take care of everyone, "from their health to their beauty". For him, skin and hair care products require the same level of care as medication.
1976 Nature at the heart of the Group Selecting the right plant varieties, cultivating in a more respectful way, building a plant extraction plant in Gaillac, creating laboratories and botanical gardens, revealing the properties of Avène-les-Bains thermal spring water and formulating plant-based health and care products: this passion that runs through its veins is the lifeblood of the Group.
1999 The Pierre Fabre Foundation 86% of Pierre Fabre's shares are held by the Pierre Fabre Foundation, which was recognized as a public utility in 1999, and secondarily by its employees through an employee shareholding plan. Pierre Fabre wanted the Foundation to become the Group's main shareholder by designating it as its universal legatee. This is a unique model in France, since it is the only French company to pay 86% of its dividends for the common good. Born from the indignation of its founder at the scourge of counterfeit medicines in Africa, the Foundation has been working since its creation to improve access to healthcare for populations in the South, in conjunction with local actors.
2005 A human adventure above all In 2005, the Ruscus shareholding plan was set up. Today, nearly 9 out of 10 employees are shareholders, associated with the Group's results and thus contributing to its independence. In November 2021, the American magazine Forbes published its annual ranking of the world's best employers. At the top of the ranking is the Pierre Fabre Group, a testimony to its reputation in the industry and to the attachment of its employees to their company.
2011 Launch of Sterile Cosmetics Sterile Cosmetics is currently the first and only solution to offer formulas with a minimum of components, containing only essential active ingredients for the most sensitive skin, without any preservatives. A new generation of dermo-cosmetic products carried by the brands Eau Thermale Avène, A-Derma and Ducray.
2013 Pierre Fabre bequeaths his company to a foundation of public utility
To ensure the company's future and avoid financial speculation, Pierre Fabre bequeathed all of his shares to the eponymous Foundation, recognized as being of public utility since 1999. This was the last altruistic and innovative gesture of a visionary entrepreneur, driven throughout his life by humanist values in the service of patients and his native region. A shareholding structure unique in France for an industrial company of this size.
2018 - Skin cancer, a new hopeful treatment In 2015, the Pierre Fabre Group signed a global partnership with Array BioPharma, an American biotech based in Colorado. The aim was to develop and market a targeted cancer therapy combining two new-generation molecules. At the end of 2018, the European Medicines Agency (EMA) authorized the marketing of this new treatment for adult patients with advanced melanoma carrying the BRAF mutation. In 2020, Pierre Fabre receives marketing authorization for one of these two molecules for the treatment of metastatic colorectal cancer with BRAF mutation (in combination with another molecule), a first in Europe.
2022 - The Pierre Fabre Group opens its doors for its 60th anniversary Pierre Fabre Village from July 7 to 10 Located on the emblematic Pierre Fabre La Michonne site in Castres, a village presenting the group's activities will be entirely created and open to all. A unique event to come and meet the group's employees who will be leading educational workshops, conferences and interactive stands. Opening of the Soual plant and the Botanical Conservatory to the public from June 2022 For the first time, the Pierre Fabre Group is opening the doors of its Botanical Conservatory located in Cambounet sur le Sor and its dermo-cosmetic production plant in Soual. Once a week, the general public will have the privilege of going behind the scenes of 2 new places to understand the origins, the functioning and the ambitions of the Group. Much more than a guided tour, it is a journey into the Pierre Fabre universe, discovering more than 240 plants used in the group's products, the actions taken to preserve them, as well as the way in which the dermo-cosmetic products are manufactured before being sold in pharmacies and parapharmacies.
The certification enables him to progress in his objectives to use his business to generate a positive impact..
International beauty packaging manufacturer and supplier Quadpack has been awarded the Benefit Corporation certificate by B Lab. This demonstrates the company's compliance with rigorous standards of social and environmental performance, public transparency and legal accountability in balancing profit and purpose. Quadpack joins a panel of over 4,000 B Corp companies worldwide who share a common goal: a world of positive impact business.
Sustainability is central to Quadpack's growth and development. Through its employees, processes and products, it aims to have a positive impact on the environment and society. Key actions in this approach include the Quadpack Foundation, its product strategy to transform the QLine portfolio, its action plan to achieve net zero emissions operations and improvements in governance, among others.
Tim Eaves, CEO of Quadpack, explains: "Quadpack has grown through collaboration and shared values, working hand in hand with our stakeholders. As a packaging company, we are conscious of the impact of our industry. As a B Corp, we pursue our goals by using our business for the long-term benefit of our communities and the environment. Our B Corp status will help us to focus on areas where we can improve and make a difference - as a company and a driving force in the packaging sector, we hope to encourage other companies to join us."
B Corp provides Quadpack with a framework for measuring its progress in five key impact areas: governance, employees, community, environment and customers. B Corp certification means that Quadpack's commitment to pursuing its goals beyond profit is legally embedded in the company's day-to-day actions.
Pablo Sanchez, executive director of B Lab Spain, explains: "The recent attention given to the packaging industry shows that Quadpack's B Corp certification is a positive initiative and signals a move towards greater accountability and transparency in the sector. Together, we are evolving our economic system to benefit all, to ensure equality and collaboration. Quadpack will be a valuable addition to the community as exchanges continue."
Quadpack is also committed to the United Nations Global Compact and holds an EcoVadis Gold rating.
Bringing together exhibitors who are always at the cutting edge of technology and in tune with market expectations, Pharmatech Cosmetech will highlight the innovations proposed by industry professionals through a trail of new products.
With a view to offering buyers and prescribers a top-quality event, the show has made every effort to provide an enlightened vision of the development prospects for the beauty and health sectors. To this end, Pharmatech Cosmetech has enlisted the help of renowned experts and industry emblems to offer a variety of opportunities for exchange on sector-specific issues, both technological (the Technos Challenges) and regulatory (ingredients).
Ever more innovative exhibitors
The Pharmatech Cosmetech trade show is a meeting place for new applications in the pharmaceutical and cosmetics industries, industrial equipment, safety and traceability, engineering and service, logistics and packaging.
Thanks to the new products trail, visitors will be able to spot the latest innovations that will enable them to improve their manufacturing processes. Prescribers and operational decision-makers from the pharmaceutical, cosmetics, chemical and biological industries will be able to take note of the efforts made in terms of quality and hygiene measurement and control. What's more, this year's show will provide visitors with a new products booklet listing the many innovations on offer from exhibitors. In this way, they can not only prepare their visit, but also keep a record of it at the end of the 3-day show.
The demonstration area run by Collectif Continuité Numérique
To help manufacturers manage their businesses more intelligently and flexibly, the Collectif Continuité Numérique (CCN), a consortium of eight industry and IT leaders1, offers pre-integrated solutions for digital transformation. As the driving force behind Industry 4.0, the collective will be exhibiting Axelle, an automated, intelligent and learning assembly line with sleek, uncluttered lines. The CCN's first concept-machine, Axelle demonstrates that Industry 4.0 offers the opportunity to place people at the heart of the company. A concentrate of innovation, this assembly line combines and interconnects the most advanced technologies from the various members of the Collectif Continuité Numérique.
A show that reinvents itself in the face of a fast-changing industry
While the exhibitors innovate, the show organizers are not to be outdone, with each new edition offering events in line with developments in the sector. For its 4th edition, the 3-day show will feature a number of highlights, including analyses and exchanges on new trends in the beauty and health sectors.
Techno Challenges
Cosmetic Valley and its Beauty Hub, a technology laboratory dedicated to equipment manufacturers, will be discussing strategic technological issues for the industry. On the program:
- Tuesday, May 31, 2022 at 10:30 a.m.: Techno challenge Beauty FAB#1
Preserving industrial resources: electrical energy is an essential resource for the smooth running of production tools. How can we optimize its use while preserving productivity and the environment?
Speakers: Engie and Jeanine Wach, Effienergie
- Wednesday, June 1 at 10:30 a.m.: Techno challenge Beauty FAB#2
Automated production: robotization and automation are becoming increasingly present in production workshops. What are the benefits, consequences and levers for innovation?
Speaker : Thibaud Mory, Niryo
- Thursday, June 2 at 10:30 a.m.: Techno challenge Beauty FAB#3
New galenic formulations in cosmetics and their impact on industrial facilities: cosmetics are changing shape. More and more requests are for anhydrous products. This trend is not without consequences for the industry's manufacturers. We need to adapt our industrial tools and draw inspiration from other sectors such as the pharmaceutical and food industries. What technology transfers are possible?
Speaker : Soknarun Ly, Soki Atelier
Ingredients village & NutriMarketing mini-conferences
To help players in the pharmaceutical and cosmetics industry meet new demands for transparency and environmental consideration, the show brings together innovative solutions in a brand new area: the Ingredients Village.
30-minute mini-conferences, hosted by Nutrimarketing, a marketing and nutrition consultancy firm, will round off this offer, with a precise and concise deciphering of new consumer trends. On the program:
- Tuesday May 31, 2022 at 4:30 pm: Nutricosmetics: market trends and opportunities.
- Wednesday June 1, 4pm: New beauty routines and cosmetic trends.
- Thursday June 2, 2022 from 3pm: Health at the heart of consumer concerns.
Employment area
For its 4th edition, Pharmatech Cosmetech is setting up a space dedicated to employment. Candidates will be able to find all the job offers proposed by exhibitors on the job wall, where they will be able to meet and exchange ideas directly on the spot.
Festo, ifm electronic, Inetum, Phoenix contact, Sew Usocome, SAP, SICK, Staubli in partnership with ATS solutions, OT/IT integrator
Who is it for? For consumers and professionals alike, who want to know more about Matrixyl ingredients and their incredible effectiveness in the fight against wrinkles.
What? The truth, nothing but the truth: scientific explanations, testimonials, before/after photos... And a product selector to find the right Matrixyl according to several criteria: wrinkle types, specific tests, regulations, cellular target, formulation attributes.
Why do we do this? To help consumers obtain all the information they need to make the right choices when it comes to anti-wrinkle products.
